FORT LAUDERDALE, FL--(Marketwired - December 03, 2015) - OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading Provider of clinical data management technology, announced the results of an industry wide survey to understand the challenges facing sponsors and contract research organizations (CROs) in their quest for efficient data collection. The majority of the respondents were from sponsors (biopharmaceutical organizations) and CROs, 42% and 32% respectively. At least half of respondents indicated that more than 50% of site source records are still maintained on paper.
Electronic source data (eSource) is a practical, resource-effective method to enhance the conduct and evaluation of clinical trials. Implementing eSource across the spectrum of clinical trials can be challenging, but industry experience demonstrates that eSource produces data more quickly, more accurately and less expensively than traditional paper-based methods. The survey shows that industry leaders see three primary challenges in implementing eSource:
Number of systems/instruments to connect to
Perceived cost
Technology not ready
Key survey findings are detailed in a white paper (eSource: Easier than You Think) that highlights relevant data to explain how eSource reduces site workload to improve efficiency and data quality. The top three potential benefits are:
Providing real-time data availability
Reducing transcription errors
Reducing source data verification effort
OmniComm's TrialOne® is the leading proactive eSource and clinical site automation solution. This browser-based, tablet-compatible system has a comprehensive integration with a wide range of bedside patient monitoring, telemetry and clinical devices with enhanced ability to send electrocardiography (ECG) orders to devices. TrialMaster, a market leading electronic data capture (EDC) technology, enables organizations to cost effectively implement eSource through direct integration with electronic health records; through the recording of direct instrument data capture timestamp and serial numbers in the audit trail; and through the ability for patient recorded outcomes to be entered directly into TrialMaster.
"In an age when most sources of clinical data can be captured and transmitted digitally, we should no longer be satisfied by processes that require the data to be printed and hand-entered into another system," said Keith Howells, OmniComm's SVP of product development. "Over half the studies we're managing have some kind of digital feeds today, and we expect that percentage to grow rapidly in the coming years. We've invested heavily in product features that make digital data collection as easy as possible."
Supporting Information
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world's pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit www.omnicomm.com.
Trademarks
OmniComm, TrialMaster, and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Source: Marketwired - All
Link: OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of Technology to Transform Clinical Development